From The Hill: Here's Regeneron's 9/29 press release on the results of the first 275 patients in their clinical trial. As far as I understand it (not far), their antibody cocktail is like a synthetic version of the old practice of infusing new patients with blood plasma from recovered patients (which, unfortunately, hasn't tested well...
RSS




